Stillwater Medical announced the launch of a new Ceribell Rapid EEG Brain Monitoring which provides Stillwater Medical clinicians with immediate access to EEG information, allowing triage for at-risk patients in just 5-minutes and continues to monitor for treatment optimization.
The Ceribell Rapid EEG Brain Monitoring system was developed to address limitations in EEG acquisition and interpretation so patients at risk of seizure can be triaged more quickly. The device consists of a simple headband, pocket-sized recorder with intuitive software, and an on-line portal for remote viewing. Using the Ceribell system, physicians can review EEG data, assess response to treatment and optimize care, all in real-time.
Mary Beth Hunziker, MSN, RN, ACNS-BC, CCRN, Director of Stillwater Medical’s ICU, explained that critically ill patients are at substantial risk of seizures that cannot always be detected by outward signs, and without rapid diagnosis it can lead to permanent brain injury, higher risk of morbidity and mortality, and longer hospital stays. She said Ceribell can be set up by any healthcare provider in just 5-minutes, even those with no previous training in EEG.
Guidelines from the Neurocritical Care Society recommend EEG should be initiated within 15-60 minutes when these seizures are suspected. Meeting these guidelines has proven difficult due to the limitations of conventional EEG systems, which were not designed for use in emergency situations. Without Rapid EEG, even top academic centers with 24/7 EEG capability experience a 4-hour wait-time for conventional equipment.
“This device is a game changer for Stillwater Medical,” said Hunziker. “It will provide our clinicians with the diagnostic information they need to make informed treatment decisions for some of our most vulnerable patients quickly. It’s another great example of our Stillwater Medical leadership putting patient safety at the forefront.”
“Ceribell founders saw that critically ill patients often experience undiagnosed non-convulsive seizure as a result of lack of access to EEG. Some suffered major neurological deficits while others simply did not make it. It is our mission to ensure no patients suffer unnecessary brain injury as a result of not having prompt EEG. We are excited to see visionary pioneer health care practitioners at Stillwater Medical adopting the technology and transforming their EEG capability.” Jane Chao, PhD, Co-founder and CEO of Ceribell.
